NCT00729573View on ClinicalTrials.gov

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

CompletedOBSERVATIONAL
Enrollment

518

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
HIV Infections
Interventions
DRUG

Emtricitabine/tenofovir disoproxil fumarate

200 mg/300 mg tabletas a part of MTN-003

DRUG

Emtricitabine/tenofovir disoproxil fumarate placebo

placebo tablet as a part of MTN-003

DRUG

Tenofovir disoproxil fumarate

300 mg tablet as a part of MTN-003

DRUG

Tenofovir disoproxil fumarate placebo

placebo tablet as a part of MTN-003

Trial Locations (4)

Unknown

MU-JHU Research Collaboration (MUJHU CARE LTD) CRS, Kampala

Seke South CRS, Chitungwiza

Zengeza CRS, Chitungwiza

Spilhaus CRS, Harare

Sponsors
All Listed Sponsors
collaborator

Microbicide Trials Network

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH